Altimmune Inc. (ALT)
NASDAQ: ALT
· Real-Time Price · USD
6.93
-0.22 (-3.08%)
At close: Jun 13, 2025, 3:59 PM
6.92
-0.14%
After-hours: Jun 13, 2025, 05:59 PM EDT
Altimmune Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2018 |
|---|---|---|---|
| Grant Revenue | 3.7M | 3.1M | 10.31M |
| Grant Revenue Growth | +19.35% | -69.94% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.99M | 5.09M | 4.97M | 5.59M | 5.31M | 4.33M | 4.51M | 4.76M | 4.53M | 3.81M | 4.49M | 4.41M | 4.43M | 3.78M | 4.16M | 3.66M | 3.82M | 4.11M | 4.22M | 2.55M | 2.33M | 2.01M | 2.19M | 2.23M | 2.07M | 2.42M | 1.96M | 2.93M | 2.45M | 1.59M | 3.04M | 1.79M | 3.23M | 5.17M | 3.71M | 1.44M | 1.19M | 975.79K | 1.23M | 1.82M | 2.2M |
| Selling, General, and Administrative Revenue Growth | +17.74% | +2.44% | -11.19% | +5.33% | +22.62% | -4.03% | -5.17% | +5.05% | +19.08% | -15.29% | +1.86% | -0.38% | +17.20% | -9.11% | +13.59% | -4.26% | -7.07% | -2.57% | +65.80% | +9.15% | +15.74% | -7.90% | -1.98% | +8.00% | -14.61% | +23.23% | -33.07% | +19.86% | +53.59% | -47.55% | +69.34% | -44.42% | -37.57% | +39.22% | +158.80% | +20.29% | +22.29% | -20.73% | -32.33% | -17.16% | n/a |
| Research and Development Revenue | 15.83M | 19.78M | 19.8M | 21.16M | 21.49M | 16.91M | 18.39M | 13.25M | 17.25M | 19.18M | 20.26M | 15.99M | 15.1M | 20.19M | 29.21M | 13.27M | 11.88M | 8.95M | 17.04M | 16.59M | 7.19M | 2.87M | 8.73M | 2.95M | 3.22M | 3.06M | 4.73M | 4.92M | 5.75M | 4.46M | 5.91M | 5.25M | 725.8K | 1.43M | 1.24M | 1.14M | 1.03M | 1.17M | 1.13M | 1.22M | 1.61M |
| Research and Development Revenue Growth | -19.99% | -0.11% | -6.39% | -1.55% | +27.07% | -8.04% | +38.75% | -23.17% | -10.06% | -5.34% | +26.69% | +5.89% | -25.17% | -30.89% | +120.05% | +11.74% | +32.71% | -47.48% | +2.70% | +130.88% | +150.17% | -67.09% | +196.41% | -8.47% | +4.99% | -35.19% | -3.87% | -14.41% | +28.86% | -24.48% | +12.39% | +623.99% | -49.14% | +15.39% | +8.18% | +11.08% | -12.15% | +4.05% | -7.91% | -24.24% | n/a |